Pila Pharma AB (PILA) — Cash Flow-to-Debt Ratio
Pila Pharma AB (PILA) has a Cash Flow-to-Debt Ratio of -0.82x as of June 2025, meaning its operating cash flow of Skr-1.91 Million could theoretically repay -1% of its total liabilities (Skr2.32 Million) in one year. See PILA FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pila Pharma AB Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Pila Pharma AB across 8 annual periods. Also explore net asset momentum of Pila Pharma AB to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Pila Pharma AB (2018–2025)
Year-by-year debt coverage analysis for Pila Pharma AB. For market capitalisation and broader financial context, see market cap of Pila Pharma AB.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.41x | Skr-9.19 Million | Skr1.43 Million | ▲ +21.1% |
| 2024 | -8.12x | Skr-7.82 Million | Skr963.00K | ▼ -200.3% |
| 2023 | -2.71x | Skr-4.85 Million | Skr1.79 Million | ▲ +59.6% |
| 2022 | -6.70x | Skr-9.09 Million | Skr1.36 Million | ▼ -8.4% |
| 2021 | -6.18x | Skr-9.36 Million | Skr1.51 Million | ▼ -501.6% |
| 2020 | -1.03x | Skr-2.00 Million | Skr1.95 Million | ▲ +90.1% |
| 2019 | -10.36x | Skr-5.02 Million | Skr484.68K | ▼ -86.7% |
| 2018 | -5.55x | Skr-4.56 Million | Skr821.98K | — |